%0 Editorial
%T Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy.
%A Molica S
%J Expert Rev Hematol
%V 16
%N 11
%D 2023 Jul-Dec 13
%M 37830359
%F 2.819
%R 10.1080/17474086.2023.2271170